Join our community of smart investors

Ebola fears stalk Sierra Rutile

The West African ebola outbreak and weak commodity prices have hit sentiment towards rutile miner Sierra Rutile
September 18, 2014

Events haven't been kind to rutile miner Sierra Rutile (SRX). A slide in the price of rutile - a popular source of white pigment titanium dioxide - explains the chunky first-half loss. Moreover, with the group's operations located in Sierra Leone, the West African ebola epidemic has weighed on sentiment. The shares have fallen a third since the outbreak began making news in late July.

IC TIP: Hold at 34p

The average rutile price slumped a third to $855 (£528) per tonne. An 8 per cent hike in production to 56,060 tonnes - and a 34 per cent rise in rutile sales volumes to 71,565 tonnes - only partially offset that pressure. But progress has been made with cutting unit costs, with total all-in cash costs falling 26 per cent to $627 per tonne. That's not far off management's full-year guidance of $605 per tonne.

Meanwhile, investors still await a detailed update on plans for developing the Gangama dry mining project, which could potentially produce 93,100 tonnes of rutile a year. Finance director Yves Ilunga says that Gangama has the potential to substantially cut the group's unit costs. A decision on taking the development forward could be made within six months.

RBC Capital Markets expects full-year EPS of 1¢, from 2¢ in 2013.

SIERRA RUTILE (SRX)

ORD PRICE:34pMARKET VALUE:£177m
TOUCH:33-35p12-MONTH HIGH:73pLOW: 33p
DIVIDEND YIELD:nilPE RATIO:138
NET ASSET VALUE:37¢NET DEBT:17%

Half-year to 30 JunTurnover ($m) Pre-tax profit ($m)Earnings per share (¢)Dividend per share (¢)
201366.43.80.7nil
201464.1-3.8-0.8nil
% change-3---

Ex-div:-

Payment:-

£1=$1.62